| Year |
Citation |
Score |
| 2021 |
Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. European Journal of Radiology. 140: 109752. PMID 34004428 DOI: 10.1016/j.ejrad.2021.109752 |
0.323 |
|
| 2015 |
Koenders L, Machielsen MW, van der Meer FJ, van Gasselt AC, Meijer CJ, van den Brink W, Koeter MW, Caan MW, Cousijn J, den Braber A, van 't Ent D, Rive MM, Schene AH, van de Giessen E, Huyser C, et al. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. Journal of Psychiatry & Neuroscience : Jpn. 40: 197-206. PMID 25510948 DOI: 10.1503/Jpn.140081 |
0.315 |
|
| 2015 |
Bongers P, van de Giessen E, Roefs A, Nederkoorn C, Booij J, van den Brink W, Jansen A. Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 34: 677-85. PMID 25365413 DOI: 10.1037/Hea0000167 |
0.406 |
|
| 2014 |
van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. Journal of Psychopharmacology (Oxford, England). 28: 866-73. PMID 24785761 DOI: 10.1177/0269881114531664 |
0.523 |
|
| 2014 |
de Weijer BA, van de Giessen E, Janssen I, Berends FJ, van de Laar A, Ackermans MT, Fliers E, la Fleur SE, Booij J, Serlie MJ. Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity. Diabetologia. 57: 1078-80. PMID 24500343 DOI: 10.1007/S00125-014-3178-Z |
0.316 |
|
| 2013 |
van de Giessen E, Hesse S, Caan MW, Zientek F, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Guignard R, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, Van Laere K, et al. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage. 64: 61-7. PMID 22982354 DOI: 10.1016/J.Neuroimage.2012.09.011 |
0.4 |
|
| 2013 |
van de Giessen E, la Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity (2005). 37: 754-7. PMID 22868829 DOI: 10.1038/Ijo.2012.128 |
0.472 |
|
| 2013 |
Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJ, de Bruin K, van den Brink W, Booij J. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction Biology. 18: 908-11. PMID 21955259 DOI: 10.1111/J.1369-1600.2011.00369.X |
0.54 |
|
| 2012 |
van de Giessen E, Nimgaonkar VL, Watson AM, Kodavali C, Baas F, Tanck MW, de Win MM, van den Brink W, Booij J. Association tests of striatal DAT availability and SNPs that impact a novel splice variant in the DAT gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 839. PMID 22427685 DOI: 10.2967/Jnumed.111.100271 |
0.391 |
|
| 2012 |
van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring, Md.). 20: 1738-40. PMID 22307070 DOI: 10.1038/Oby.2012.17 |
0.479 |
|
| 2012 |
van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 290-9. PMID 21889317 DOI: 10.1016/J.Euroneuro.2011.07.015 |
0.521 |
|
| 2011 |
de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B, Janssen IM, van de Laar A, Fliers E, Serlie MJ, Booij J. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. Ejnmmi Research. 1: 37. PMID 22214469 DOI: 10.1186/2191-219X-1-37 |
0.305 |
|
| 2011 |
van de Giessen E, Groot PF, Booij J, van den Brink W, Veltman DJ, Nederveen AJ. Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging. Ajnr. American Journal of Neuroradiology. 32: 903-7. PMID 21330391 DOI: 10.3174/ajnr.A2383 |
0.317 |
|
| 2011 |
Burke SM, van de Giessen E, de Win M, Schilt T, van Herk M, van den Brink W, Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine. 41: 419-29. PMID 20367893 DOI: 10.1017/S0033291710000486 |
0.434 |
|
| 2010 |
van Munster BC, Yazdanpanah M, Tanck MW, de Rooij SE, van de Giessen E, Sijbrands EJ, Zwinderman AH, Korevaar JC. Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 38-45. PMID 19309018 DOI: 10.1002/ajmg.b.30943 |
0.303 |
|
| 2009 |
Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biological Psychiatry. 65: 1091-3. PMID 19167701 DOI: 10.1016/j.biopsych.2008.12.007 |
0.305 |
|
| 2009 |
van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 45-52. PMID 19091889 DOI: 10.2967/Jnumed.108.053652 |
0.414 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, Raijmakers P, Foncke EM, van de Giessen E, Berendse HW, van den Heuvel OA. Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 904-11. PMID 24832846 DOI: 10.1002/Mds.25886 |
0.292 |
|
| 2017 |
Weinstein JJ, van de Giessen E, Rosengard RJ, Xu X, Ojeil N, Brucato G, Gil RB, Kegeles LS, Laruelle M, Slifstein M, Abi-Dargham A. PET imaging of dopamine-D2 receptor internalization in schizophrenia. Molecular Psychiatry. PMID 28507321 DOI: 10.1038/mp.2017.107 |
0.283 |
|
| 2016 |
van der Zwaal EM, de Weijer BA, van de Giessen EM, Janssen I, Berends FJ, van de Laar A, Ackermans MT, Fliers E, la Fleur SE, Booij J, Serlie MJ. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27184782 DOI: 10.1016/J.Euroneuro.2016.04.009 |
0.276 |
|
| 2015 |
Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, Hackett E, Girgis R, Ojeil N, Moore H, D'Souza D, Malison RT, Huang Y, Lim K, Nabulsi N, et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. Jama Psychiatry. 72: 316-24. PMID 25651194 DOI: 10.1001/Jamapsychiatry.2014.2414 |
0.268 |
|
| 2022 |
Wallert ED, van de Giessen E, Knol RJJ, Beudel M, de Bie RMA, Booij J. Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 27S-32S. PMID 35649651 DOI: 10.2967/jnumed.121.263197 |
0.249 |
|
| 2014 |
Hesse S, van de Giessen E, Zientek F, Petroff D, Winter K, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Darcourt J, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, et al. Association of central serotonin transporter availability and body mass index in healthy Europeans. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1240-7. PMID 24976619 DOI: 10.1016/J.Euroneuro.2014.05.005 |
0.242 |
|
| 2014 |
Booij J, Van Wieringen JP, Van de giessen E, Knol RJJ, Finnema SJ. PET and SPECT imaging of the central dopamine system in humans Pet and Spect of Neurobiological Systems. 229-248. DOI: 10.1007/978-3-642-42014-6_10 |
0.237 |
|
| 2020 |
van der Pluijm M, Cassidy C, Zandstra M, Wallert E, de Bruin K, Booij J, de Haan L, Horga G, van de Giessen E. Reliability and Reproducibility of Neuromelanin-Sensitive Imaging of the Substantia Nigra: A Comparison of Three Different Sequences. Journal of Magnetic Resonance Imaging : Jmri. PMID 33037730 DOI: 10.1002/jmri.27384 |
0.225 |
|
| 2022 |
van Hooijdonk CFM, Drukker M, van de Giessen E, Booij J, Selten JP, van Amelsvoort TAMJ. Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings. Progress in Neurobiology. 213: 102265. PMID 35351599 DOI: 10.1016/j.pneurobio.2022.102265 |
0.213 |
|
| 2013 |
Booij J, van de Giessen E, Hesse S, Sabri O. Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects. European Journal of Nuclear Medicine and Molecular Imaging. 40: 143-4. PMID 23093213 DOI: 10.1007/S00259-012-2267-9 |
0.205 |
|
| 2024 |
van Hooijdonk CFM, Balvers MGJ, van der Pluijm M, Smith CLC, de Haan L, Schrantee A, Yaqub M, Witkamp RF, van de Giessen E, van Amelsvoort TAMJ, Booij J, Selten JP. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals. Psychological Medicine. 1-11. PMID 38389452 DOI: 10.1017/S0033291724000291 |
0.194 |
|
| 2014 |
van de Giessen E, McIlwrick S, Veltman D, van de Nbrink W, Booij J. Obesity an addiction? Imaging of neurotransmitter systems in obesity Pet and Spect in Psychiatry. 641-656. DOI: 10.1007/978-3-642-40384-2_27 |
0.186 |
|
| 2010 |
van de Giessen E, Booij J. The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1507-11. PMID 20309682 DOI: 10.1007/S00259-010-1424-2 |
0.164 |
|
| 2022 |
Wallert E, Letort E, van der Zant F, Winogrodzka A, Berendse H, Beudel M, de Bie R, Booij J, Raijmakers P, van de Giessen E. Comparison of [F]-FDOPA PET and [I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome. Ejnmmi Research. 12: 68. PMID 36273088 DOI: 10.1186/s13550-022-00943-6 |
0.143 |
|
| 2013 |
Borgers AJ, Alkemade A, Van de Giessen EM, Drent ML, Booij J, Bisschop PH, Fliers E. Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus. Ejnmmi Research. 3: 34. PMID 23618227 DOI: 10.1186/2191-219X-3-34 |
0.133 |
|
| 2014 |
van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. Journal of Psychiatric Research. 58: 147-54. PMID 25145808 DOI: 10.1016/j.jpsychires.2014.07.025 |
0.12 |
|
| 2022 |
Alzghool OM, van Dongen G, van de Giessen E, Schoonmade L, Beaino W. α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35289424 DOI: 10.1002/mds.28984 |
0.118 |
|
| 2021 |
Wengler K, Cassidy C, van der Pluijm M, Weinstein JJ, Abi-Dargham A, van de Giessen E, Horga G. Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies. Journal of Magnetic Resonance Imaging : Jmri. PMID 33960063 DOI: 10.1002/jmri.27679 |
0.112 |
|
| 2020 |
Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, ... ... Van de Giessen E, et al. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32388612 DOI: 10.1007/S00259-020-04817-8 |
0.109 |
|
| 2019 |
van der Pluijm M, Sutterland AL, van Kuilenburg ABP, Zoetekouw L, de Haan L, Booij J, van de Giessen E. Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients. Therapeutic Advances in Psychopharmacology. 9: 2045125319872341. PMID 31523419 DOI: 10.1177/2045125319872341 |
0.107 |
|
| 2016 |
Van Snellenberg JX, Girgis RR, Horga G, van de Giessen E, Slifstein M, Ojeil N, Weinstein JJ, Moore H, Lieberman JA, Shohamy D, Smith EE, Abi-Dargham A. Mechanisms of Working Memory Impairment in Schizophrenia. Biological Psychiatry. PMID 27056754 DOI: 10.1016/J.Biopsych.2016.02.017 |
0.107 |
|
| 2022 |
van der Pluijm M, Wallert ED, Coolen BF, Tjong Tjin Joe KT, de Haan L, Booij J, van de Giessen E. Acceleration of neuromelanin-sensitive MRI sequences in the substantia nigra using standard MRI options. Neuroradiology. PMID 36169662 DOI: 10.1007/s00234-022-03058-w |
0.105 |
|
| 2024 |
van der Pluijm M, Alting M, Schrantee A, Edden RAE, Booij J, de Haan L, van de Giessen E. Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients. Schizophrenia Research. 264: 471-478. PMID 38277736 DOI: 10.1016/j.schres.2024.01.025 |
0.104 |
|
| 2023 |
Henssen D, Leijten L, Meijer FJA, van der Kolk A, Arens AIJ, Ter Laan M, Smeenk RJ, Gijtenbeek A, van de Giessen EM, Tolboom N, Oprea-Lager DE, Smits M, Nagarajah J. Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma. Cancers. 15. PMID 37174097 DOI: 10.3390/cancers15092631 |
0.098 |
|
| 2022 |
Wamelink IJHG, Kuijer JPA, Padrela BE, Zhang Y, Barkhof F, Mutsaerts HJMM, Petr J, van de Giessen E, Keil VC. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma. Journal of Magnetic Resonance Imaging : Jmri. PMID 35633282 DOI: 10.1002/jmri.28239 |
0.094 |
|
| 2021 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, ... van de Giessen E, et al. EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34882261 DOI: 10.1007/s00259-021-05603-w |
0.089 |
|
| 2023 |
van Hooijdonk CFM, van der Pluijm M, de Vries BM, Cysouw M, Alizadeh BZ, Simons CJP, van Amelsvoort TAMJ, Booij J, Selten JP, de Haan L, Schirmbeck F, van de Giessen E. The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach. Schizophrenia Research. 262: 132-141. PMID 37950936 DOI: 10.1016/j.schres.2023.10.030 |
0.088 |
|
| 2008 |
van de Giessen E, Fogh I, Gopinath S, Smith B, Hu X, Powell J, Andersen P, Nicholson G, Al Chalabi A, Shaw CE. Association study on glutathione S-transferase omega 1 and 2 and familial ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 81-4. PMID 18427999 DOI: 10.1080/17482960701702553 |
0.087 |
|
| 2023 |
Coomans EM, de Koning LA, Rikken RM, Verfaillie SCJ, Visser D, den Braber A, Tomassen J, van de Beek M, Collij LE, Lemstra AW, Windhorst AD, Barkhof F, Golla SSV, Visser PJ, Scheltens P, ... ... van de Giessen E, et al. Performance of a [F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies. Neurology. 101: e1850-e1862. PMID 37748892 DOI: 10.1212/WNL.0000000000207794 |
0.079 |
|
| 2023 |
Verveen A, Verfaillie SCJ, Visser D, Csorba I, Coomans EM, Koch DW, Appelman B, Barkhof F, Boellaard R, de Bree G, van de Giessen EM, Golla S, van Heugten CM, Horn J, Hulst HE, et al. Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO). Bmj Open. 13: e072611. PMID 37399444 DOI: 10.1136/bmjopen-2023-072611 |
0.075 |
|
| 2020 |
Morbelli S, Ekmekcioglu O, Barthel H, Albert NL, Boellaard R, Cecchin D, Guedj E, Lammertsma AA, Law I, Penuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Varrone A, Garibotto V, et al. COVID-19 and the brain: impact on nuclear medicine in neurology. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32700058 DOI: 10.1007/S00259-020-04965-X |
0.072 |
|
| 2022 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, ... van de Giessen E, et al. Correction to: EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. 49: 2100-2101. PMID 35254483 DOI: 10.1007/s00259-022-05755-3 |
0.069 |
|
| 2023 |
van Lith SAM, Pruis IJ, Tolboom N, Snijders TJ, Henssen D, Ter Laan M, Te Dorsthorst M, Leenders WPJ, Gotthardt M, Nagarajah J, Robe PA, De Witt Hamer P, Hendrikse H, Oprea-Lager DE, Yaqub M, ... ... van de Giessen E, et al. PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37652540 DOI: 10.2967/jnumed.123.265738 |
0.066 |
|
| 2023 |
Slagboom TNA, Stenvers DJ, van de Giessen E, Roosendaal SD, de Win MML, Bot JCJ, Aronica E, Post R, Hoogmoed J, Drent ML, Pereira AM. Continuing Challenges in the Definitive Diagnosis of Cushing's Disease: A Structured Review Focusing on Molecular Imaging and a Proposal for Diagnostic Work-Up. Journal of Clinical Medicine. 12. PMID 37109254 DOI: 10.3390/jcm12082919 |
0.064 |
|
| 2023 |
Dubbelman MA, Hendriksen HMA, Harrison JE, Vijverberg EGB, Prins ND, Kroeze LA, Ottenhoff L, Van Leeuwenstijn MMSSA, Verberk IMW, Teunissen CE, van de Giessen EM, Van Harten AC, Van Der Flier WM, Sikkes SAM. Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups. Neurology. 102: e207978. PMID 38165338 DOI: 10.1212/WNL.0000000000207978 |
0.059 |
|
| 2020 |
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8 |
0.059 |
|
| 2023 |
Visser D, Verfaillie SCJ, Bosch I, Brouwer I, Tuncel H, Coomans EM, Rikken RM, Mastenbroek SE, Golla SSV, Barkhof F, van de Giessen E, van Berckel BNM, van der Flier WM, Ossenkoppele R. Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36976303 DOI: 10.1007/s00259-023-06196-2 |
0.056 |
|
| 2023 |
Padrela BE, Lorenzini L, Collij LE, García DV, Coomans E, Ingala S, Tomassen J, Deckers Q, Shekari M, Geus EJ, van de Giessen E, Kate MT, Visser PJ, Barkhof F, Petr J, et al. Genetic, vascular, and amyloid components of cerebral blood flow in a preclinical population. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X231178993. PMID 37231665 DOI: 10.1177/0271678X231178993 |
0.053 |
|
| 2023 |
Wamelink IJHG, Hempel HL, van de Giessen E, Vries MHM, De Witt Hamer P, Barkhof F, Keil VC. The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study. Journal of Neuro-Oncology. PMID 36977844 DOI: 10.1007/s11060-023-04290-x |
0.05 |
|
| 2023 |
Collij LE, Farrar G, Zwan M, van de Giessen E, Ossenkoppele R, Barkhof F, Rozemuller AJM, Pijnenburg YAL, van der Flier WM, Bouwman F. Clinical outcomes up to 9 years after [F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimer's Research & Therapy. 15: 207. PMID 38012799 DOI: 10.1186/s13195-023-01351-1 |
0.049 |
|
| 2021 |
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S, et al. The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34272989 DOI: 10.1007/s00259-021-05485-y |
0.043 |
|
| 2021 |
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S, et al. The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34272989 DOI: 10.1007/s00259-021-05485-y |
0.043 |
|
| 2024 |
Dubbelman MA, Tomassen J, van der Landen SM, Bakker E, Kamps S, van Unnik AAJM, van de Glind MABJ, van der Vlies AE, Koene T, Leeuwis AE, Barkhof F, van Harten AC, Teunissen C, van de Giessen E, Lemstra AW, et al. Visual associative learning to detect early episodic memory deficits and distinguish Alzheimer's disease from other types of dementia. Journal of the International Neuropsychological Society : Jins. 1-10. PMID 38389489 DOI: 10.1017/S1355617724000079 |
0.038 |
|
| 2015 |
Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chételat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata' S, Payoux P, Pagani M. A Cochrane review on brain [(18)F]FDG PET in dementia: limitations and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1487-91. PMID 26067090 DOI: 10.1007/S00259-015-3098-2 |
0.038 |
|
| 2016 |
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, ... ... Van De Giessen E, et al. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27987029 DOI: 10.1007/S00259-016-3598-8 |
0.035 |
|
| 2023 |
Moonen JEF, Haan R, Bos I, Teunissen C, van de Giessen E, Tomassen J, den Braber A, van der Landen SM, de Geus EJC, Legdeur N, van Harten AC, Trieu C, de Boer C, Kroeze L, Barkhof F, et al. Contributions of amyloid beta and cerebral small vessel disease in clinical decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38146222 DOI: 10.1002/alz.13607 |
0.034 |
|
| 2016 |
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Saraf LJ, Lammertsma AA, Law I, ... ... Van De Giessen E, et al. The need of standardization and of large clinical studies in an emerging indication of [(18)F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27924371 DOI: 10.1007/S00259-016-3589-9 |
0.027 |
|
| 2021 |
Chételat G, Arbizu J, Barthel H, Garibotto V, Lammertsma AA, Law I, Morbelli S, van de Giessen E, Drzezga A. Finding our way through the labyrinth of dementia biomarkers. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33876260 DOI: 10.1007/s00259-021-05301-7 |
0.027 |
|
| Hide low-probability matches. |